Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
| Main Author: | |
|---|---|
| Publication Date: | 2018 |
| Other Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | eng |
| Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| Download full: | http://hdl.handle.net/10362/147031 |
Summary: | This work was supported by the Bluepharma innovation award "Trifunctional antibodies and dendritic cell-based technologies: a combined approach to cancer immunotherapy" 2013 and the Scientific merit prize Santander - Totta - Lisbon New University - "Antibody engineering for breast cancer therapy" 2013. LRL is supported by the grant PD/BD/52476/2013 from the Portuguese Foundation for Science and Technology (FCT). The work is partially supported by FCT-MCTES through the grants IF/00033/2012 (ASP), SFRH/BPD/101827/2014 (LL) and SFRH/BPD/111048/2015 (JAF), the Wellcome Trust Biomedical Resource grant (WC) and the NSFC-Shandong Joint Fund (U1606403) (CL). The authors also acknowledge FCT funding for CI-IPOP research unit (PEst-OE/SAU/UI0776/201). co-financed by the European Regional Development Fund under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). The funders did not play a role in the study design, data collection or decision to publish. |
| id |
RCAP_874b42fa3c20a9274bd814a96b6da700 |
|---|---|
| oai_identifier_str |
oai:run.unl.pt:10362/147031 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository_id_str |
https://opendoar.ac.uk/repository/7160 |
| spelling |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acidsGeneralSDG 3 - Good Health and Well-beingThis work was supported by the Bluepharma innovation award "Trifunctional antibodies and dendritic cell-based technologies: a combined approach to cancer immunotherapy" 2013 and the Scientific merit prize Santander - Totta - Lisbon New University - "Antibody engineering for breast cancer therapy" 2013. LRL is supported by the grant PD/BD/52476/2013 from the Portuguese Foundation for Science and Technology (FCT). The work is partially supported by FCT-MCTES through the grants IF/00033/2012 (ASP), SFRH/BPD/101827/2014 (LL) and SFRH/BPD/111048/2015 (JAF), the Wellcome Trust Biomedical Resource grant (WC) and the NSFC-Shandong Joint Fund (U1606403) (CL). The authors also acknowledge FCT funding for CI-IPOP research unit (PEst-OE/SAU/UI0776/201). co-financed by the European Regional Development Fund under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). The funders did not play a role in the study design, data collection or decision to publish.Incomplete O-glycosylation is a feature associated with malignancy resulting in the expression of truncated glycans such as the sialyl-Tn (STn) antigen. Despite all the progress in the development of potential anti-cancer antibodies, their application is frequently hindered by low specificities and cross-reactivity. In this study, a novel anti-STn monoclonal antibody named L2A5 was developed by hybridoma technology. Flow cytometry analysis showed that L2A5 specifically binds to sialylated structures on the cell surface of STn-expressing breast and bladder cancer cell lines. Moreover, immunoblotting assays demonstrated reactivity to tumour-associated O-glycosylated proteins, such as MUC1. Tumour recognition was further observed using immunohistochemistry assays, which demonstrated a high sensitivity and specificity of L2A5 mAb towards cancer tissue, using bladder and colorectal cancer tissues. L2A5 staining was exclusively tumoural, with a remarkable reactivity in invasive and metastasis sites, not detectable by other anti-STn mAbs. Additionally, it stained 20% of cases of triple-negative breast cancers, suggesting application in diseases with unmet clinical needs. Finally, the fine specificity was assessed using glycan microarrays, demonstrating a highly specific binding of L2A5 to core STn antigens and additional ability to bind 2–6-linked sialyl core-1 probes. In conclusion, this study describes a novel anti-STn antibody with a unique binding specificity that can be applied for cancer diagnostic and future development of new antibody-based therapeutic applications.UCIBIO - Applied Molecular Biosciences UnitDCV - Departamento de Ciências da VidaDQ - Departamento de QuímicaRUNLoureiro, Liliana R.Sousa, Diana P.Ferreira, DylanChai, WengangLima, Luís Carlos OliveiraPereira, CarinaLopes, Carla B.Correia, Viviana G.Silva, Lisete M.Li, ChunxiaSantos, Lúcio LaraFerreira, José AlexandreBarbas, AnaPalma, Angelina S.Novo, CarlosVideira, Paula A.2023-01-05T22:13:24Z2018-12-012018-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/147031eng2045-2322PURE: 16666184https://doi.org/10.1038/s41598-018-30421-winfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-10-07T01:36:58Zoai:run.unl.pt:10362/147031Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:38:19.540120Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
| dc.title.none.fl_str_mv |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| title |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| spellingShingle |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids Loureiro, Liliana R. General SDG 3 - Good Health and Well-being |
| title_short |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| title_full |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| title_fullStr |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| title_full_unstemmed |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| title_sort |
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids |
| author |
Loureiro, Liliana R. |
| author_facet |
Loureiro, Liliana R. Sousa, Diana P. Ferreira, Dylan Chai, Wengang Lima, Luís Carlos Oliveira Pereira, Carina Lopes, Carla B. Correia, Viviana G. Silva, Lisete M. Li, Chunxia Santos, Lúcio Lara Ferreira, José Alexandre Barbas, Ana Palma, Angelina S. Novo, Carlos Videira, Paula A. |
| author_role |
author |
| author2 |
Sousa, Diana P. Ferreira, Dylan Chai, Wengang Lima, Luís Carlos Oliveira Pereira, Carina Lopes, Carla B. Correia, Viviana G. Silva, Lisete M. Li, Chunxia Santos, Lúcio Lara Ferreira, José Alexandre Barbas, Ana Palma, Angelina S. Novo, Carlos Videira, Paula A. |
| author2_role |
author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
UCIBIO - Applied Molecular Biosciences Unit DCV - Departamento de Ciências da Vida DQ - Departamento de Química RUN |
| dc.contributor.author.fl_str_mv |
Loureiro, Liliana R. Sousa, Diana P. Ferreira, Dylan Chai, Wengang Lima, Luís Carlos Oliveira Pereira, Carina Lopes, Carla B. Correia, Viviana G. Silva, Lisete M. Li, Chunxia Santos, Lúcio Lara Ferreira, José Alexandre Barbas, Ana Palma, Angelina S. Novo, Carlos Videira, Paula A. |
| dc.subject.por.fl_str_mv |
General SDG 3 - Good Health and Well-being |
| topic |
General SDG 3 - Good Health and Well-being |
| description |
This work was supported by the Bluepharma innovation award "Trifunctional antibodies and dendritic cell-based technologies: a combined approach to cancer immunotherapy" 2013 and the Scientific merit prize Santander - Totta - Lisbon New University - "Antibody engineering for breast cancer therapy" 2013. LRL is supported by the grant PD/BD/52476/2013 from the Portuguese Foundation for Science and Technology (FCT). The work is partially supported by FCT-MCTES through the grants IF/00033/2012 (ASP), SFRH/BPD/101827/2014 (LL) and SFRH/BPD/111048/2015 (JAF), the Wellcome Trust Biomedical Resource grant (WC) and the NSFC-Shandong Joint Fund (U1606403) (CL). The authors also acknowledge FCT funding for CI-IPOP research unit (PEst-OE/SAU/UI0776/201). co-financed by the European Regional Development Fund under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). The funders did not play a role in the study design, data collection or decision to publish. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018-12-01 2018-12-01T00:00:00Z 2023-01-05T22:13:24Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/147031 |
| url |
http://hdl.handle.net/10362/147031 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
2045-2322 PURE: 16666184 https://doi.org/10.1038/s41598-018-30421-w |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
| instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| repository.mail.fl_str_mv |
info@rcaap.pt |
| _version_ |
1833596851012501504 |